P.02.20 SUPPLEMENTATION WITH LACTOBACILLUS REUTERI ATCC PTA 4659 IN PATIENTS AFFECTED BY ACUTE UNCOMPLICATED DIVERTICULITIS: A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED TRIAL

Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial

International Journal of Colorectal Disease ◽

10.1007/s00384-019-03295-1 ◽

2019 ◽

Vol 34 (6) ◽

pp. 1087-1094 ◽

Cited By ~ 1

Author(s):

Carmine Petruzziello ◽

Alessio Migneco ◽

Silvia Cardone ◽

Marcello Covino ◽

Angela Saviano ◽

...

Keyword(s):

Lactobacillus Reuteri ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Comments on “Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial”

International Journal of Colorectal Disease ◽

10.1007/s00384-019-03335-w ◽

2019 ◽

Vol 34 (8) ◽

pp. 1503-1504

Author(s):

Jiezhong Chen ◽

Luis Vitetta

Keyword(s):

Lactobacillus Reuteri ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Effects of non‐viable Lactobacillus reuteri combining with 14‐day standard triple therapy on Helicobacter pylori eradication: A randomized double‐blind placebo‐controlled trial

Helicobacter ◽

10.1111/hel.12856 ◽

2021 ◽

Author(s):

Chenghai Yang ◽

Liping Liang ◽

Pinjing Lv ◽

Le Liu ◽

Siqi Wang ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Lactobacillus Reuteri ◽

Controlled Trial ◽

Double Blind ◽

Helicobacter Pylori Eradication ◽

Double Blind Placebo ◽

Standard Triple Therapy

Tu1750 – Novel Rifamycin Sv Multi-Matrix Formulation for Treatment of Acute Uncomplicated Diverticulitis: Results of a Prospective Double-Blind, Placebo-Controlled, Randomized Study

Gastroenterology ◽

10.1016/s0016-5085(19)39736-7 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1110-S-1111

Author(s):

Wolfgang Kruis ◽

Tomas Poskus ◽

Guenter Boehm ◽

Ivan Bunganic ◽

István Rácz ◽

...

Keyword(s):

Randomized Study ◽

Matrix Formulation ◽

Double Blind ◽

Double Blind Placebo ◽

Rifamycin Sv ◽

Lactobacillus reuteri DSM 17938 for the Management of Infantile Colic in Breastfed Infants: A Randomized, Double-Blind, Placebo-Controlled Trial

The Journal of Pediatrics ◽

10.1016/j.jpeds.2012.08.004 ◽

2013 ◽

Vol 162 (2) ◽

pp. 257-262 ◽

Cited By ~ 126

Author(s):

Hania Szajewska ◽

Ewa Gyrczuk ◽

Andrea Horvath

Keyword(s):

Lactobacillus Reuteri ◽

Controlled Trial ◽

Infantile Colic ◽

Double Blind ◽

Double Blind Placebo ◽

Breastfed Infants

Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial

The Journal of Pediatrics ◽

10.1016/j.jpeds.2016.04.003 ◽

2016 ◽

Vol 174 ◽

pp. 160-164.e1 ◽

Cited By ~ 25

Author(s):

Zvi Weizman ◽

Jaber Abu-Abed ◽

Mauricio Binsztok

Keyword(s):

Abdominal Pain ◽

Lactobacillus Reuteri ◽

Controlled Trial ◽

Functional Abdominal Pain ◽

Double Blind ◽

Double Blind Placebo

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

Microbes and Infection ◽

10.1016/j.micinf.2006.01.003 ◽

2006 ◽

Vol 8 (6) ◽

pp. 1450-1454 ◽

Cited By ~ 154

Author(s):

Kingsley Anukam ◽

Emmanuel Osazuwa ◽

Ijeoma Ahonkhai ◽

Michael Ngwu ◽

Gibson Osemene ◽

...

Keyword(s):

Bacterial Vaginosis ◽

Lactobacillus Reuteri ◽

Controlled Trial ◽

Lactobacillus Rhamnosus ◽

Double Blind ◽

Double Blind Placebo ◽

Probiotic Lactobacillus

A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children

Iranian Journal of Pediatrics ◽

10.5812/ijp.2616 ◽

2015 ◽

Vol 25 (6) ◽

Cited By ~ 15

Author(s):

Kambiz Eftekhari ◽

Zahra Vahedi ◽

Mojtaba Kamali Aghdam ◽

Diana Noemi Diaz

Keyword(s):

Abdominal Pain ◽

Lactobacillus Reuteri ◽

Controlled Trial ◽

Functional Abdominal Pain ◽

Double Blind ◽

Double Blind Placebo

Lack of an Effect of Lactobacillus reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: A Randomized, Double-Blind, Placebo-Controlled Trial

The Journal of Pediatrics ◽

10.1016/j.jpeds.2011.12.049 ◽

2012 ◽

Vol 161 (1) ◽

pp. 40-43.e1 ◽

Cited By ~ 29

Author(s):

Monika Wanke ◽

Hania Szajewska

Keyword(s):

Lactobacillus Reuteri ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nosocomial Diarrhea

Faculty Opinions recommendation of The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725305163.793506054 ◽

2015 ◽

Author(s):

Mellar Davis

Keyword(s):

Lactobacillus Reuteri ◽

Controlled Trial ◽

Functional Constipation ◽

Double Blind ◽

Double Blind Placebo